Investigational Site Number 616006

Bialystok 15-069

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Squamous Cell Lung Cancer

Studies at this site

• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
• Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed